Connext
Business Services · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
79 Dongnae-ro Ste 505, Daegu, Gyeongsang...Website
www.connext.co.krRevenue
<$5 MillionIndustry
About Connext
Connext Org Chart
Is Connext your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Connext recently announced quarterly report
Click to see if Connext had a recent Job posting/layoffs
Connext, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Connext is spiking on competitors!
Check if Connext has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Connext
Funding: Get notified immidiatlly once Connext has new funding data
Product Launch: Get notified when Connext launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Connext is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Connext is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Connext.
Connext Tech Stack
A closer look at the technologies used by Connext
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Connext
Founded in 2017, CONNEXT is a clinical-stage biotech venture focused on developing biopharmaceuticals to improve quality of life. The company is working on innovative treatments using a recombinant TLR5 agonist to prevent side effects from cancer and radiation therapies, as well as the world's first recombinant collagenase treatment. With a portfol... Read More